Enhanced negative chronotropy by inhibitory receptors in transgenic heart overexpressing β2-adrenoceptors

Journal of the Autonomic Nervous System

Volumn 79, Issue 2-3, 2000, Pages 108-116

  Du, Xiao Jun ^a   Vincan, Elizabeth ^a   Percy, Elodie ^a   Woodcock, Elizabeth A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

G(i) protein; Heart rate; Mouse; Muscarinic receptor; Pertussis toxin; Purinergic receptor; Vagal nerves

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 8 (2 AMINO 4 CHLOROPHENYL) 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE RECEPTOR; ATROPINE; BETA 2 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PERTUSSIS TOXIN; PURINE P1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; ELECTROSTIMULATION; GENE EXPRESSION; HEART; HEART PERFUSION; HEART RATE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VAGUS NERVE STIMULATION;

ACETYLCHOLINE; ADENOSINE; AMINOQUINOLINES; ANIMALS; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANYLATE CYCLASE; HEART RATE; MICE; MICE, TRANSGENIC; MYOCARDIUM; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PERTUSSIS TOXIN; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, PURINERGIC; VIRULENCE FACTORS, BORDETELLA;

EID: 0033977484     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(00)00070-9     Document Type: Article

References (36)

1. Adamson P.B., Hull S.S. Jr., Vanoli E., De Ferrari G.M., Wisler P., Foreman R.D., Watanabe A.M., Schwartz P.J. Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. Am. J. Physiol. 265:1993;H734-H740.
2. Balligand J.L., Kobzik L., Han X., Kaye D.M., Belhassen L., O'Hara D.S., Kelly R.A., Smith T.W., Michel T. Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270:1995;14582-14586.
3. 2-adrenoceptor. Nature. 374:1995;272-276.
4. i proteins. Am. J. Physiol. 272:1997;H1672-H1679.
5. 2-adrenergic receptors. Am. J. Physiol. 271:1996;H630-H636.
6. i-protein expression and in carbachol sensitivity. Eur. Heart. J. 12:(Suppl F):1991;127-131.
7. iα2 in human end-stage heart failure. Circ. Res. 70:1992;688-696.
8. Eschenhagen T., Mende U., Diederich M., Hertle B., Memmesheimer C., Pohl A., Schmitz W., Scholz H., Steinfath M., Bohm M., Michel M.C., Brodde O.E., Raap A. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia. Circulation. 93:1996;763-771.
9. Feron O., Dessy C., Opel D.J., Arstall M.A., Kelly R.A., Michel T. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J. Biol. Chem. 273:1998;30249-30254.
10. Fleming J.W., Hodges T.D., Watanabe A.M. Pertussis toxin-treated dog: A whole animal model of impaired inhibitory regulation of adenylate cyclase. Circ. Res. 62:1988;992-1000.
11. Gallo M., Ghigo P.D., Bosia A., Alloatti G., Costamagna C., Penna C., Levi R.C. Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. J. Physiol. (Lond). 506:1998;639-651.
12. Gettys T.W., Sheriff-Carter K., Moomaw J., Taylor I.L., Raymond J.R. Characterization and use of crude α-subunit preparations for quantitative immunoblotting of G proteins. Anal. Biochem. 220:1994;82-91.
13. Han X., Shimoni Y., Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol. (Lond). 476:1994;303-314.
14. Han X., Shimoni Y., Giles W.R. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J. Gen. Physiol. 106:1995;45-65.
15. Han X., Kobzik L., Severson D., Shimoni Y. Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node. J. Physiol. (Lond). 509:1998;741-754.
16. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 95:1998;6510-6515.
17. Hare J.M., Kim B., Flavahan N.A., Ricker K.M., Peng X., Colman L., Weiss R.G., Kass D.A. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J. Clin. Invest. 101:1998;1424-1431.
18. Irisawa H., Brown H.F., Giles W. Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 73:1993;197-227.
19. Jumrussirikul P., Dinerman J., Dawson T.M., Dawson V.L., Ekelund U., Georgakopoulos D., Schramm L.P., Calkins H., Snyder S.H., Hare J.M., Berger R.D. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J. Clin. Invest. 102:1998;1279-1285.
20. Koumi S., Sato R., Nagasawa K., Hayakawa H. Activation of inwardly rectifying potassium channels by muscarinic receptor-linked G protein in isolated human ventricular myocytes. J. Membr. Biol. 157:1997;71-81.
21. + channel activation. J. Biol. Chem. 273:1998;16946-16952.
22. Kubalak S., Newman W.W.H., Webb J.G. Differential effect of pertussis toxin on adenosine and muscarinic inhibition of cyclic AMP accumulation in canine ventricular myocytes. J. Mol. Cell. Cardiol. 23:1991;199-205.
23. Le Guludec D., Cohen-Solal A., Delforge J., Delahaye J., Syrota A., Merlet P. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. Circulation. 96:1997;3416-3422.
24. MacLeod K.M., Diamond J. Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations. J. Pharmacol. Exp. Ther. 238:1996;313-318.
25. 2-purinoceptors in guinea-pig atrial myocytes. J. Physiol. (Lond). 497:1996;379-393.
26. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 268:1993;26286-26295.
27. 2-adrenergic receptor. Science. 264:1994;582-586.
28. Reithmann C., Werdan K. Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein α-subunits. Naunyn Schmiedebergs Arch. Pharmacol. 351:1995;27-34.
29. Reithmann C., Panzner B., Werdan K. Distinct pathways for β-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein α-subunits in chicken cardiomyocytes. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;530-540.
30. Schmidt M.J., Sawyer B.D., Truex L.L., Marshall W.S., Fleisch J.H. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232:1985;764-769.
31. K+-Ach, in intact cells. Proc. Natl. Acad. Sci. USA. 94:1997;7921-7926.
32. Sterin-Borda L., Echague A.V., Leiros C.P., Genaro A., Borda E. Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br. J. Pharmacol. 115:1995;1525-1531.
33. sα. Circ. Res. 82:1998;416-423.
34. i during pacing-induced heart failure. Circulation. 94:1996;102-107.
35. Wickman K.D., Iniguez-Lluhl J.A., Davenport P.A., Taussig R., Krapivinsky G.B., Linder M.E., Gilman A.G., Clapham D.E. Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel. Nature. 368:1994;255-257.
36. Yatani A., Brown A.M. Rapid β-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science. 245:1998;71-74.